STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.
作者： Krzysztof Sikorski , Anna Czerwoniec , Janusz M. Bujnicki , Joanna Wesoly , Hans A.R. Bluyssen
DOI: 10.1016/J.CYTOGFR.2011.06.003
关键词:
摘要: … STAT1-dependent synergism between IFNγ and TLR in ECs and atheroma interacting immune cells … These findings suggest that in immune cells STAT1 is a critical point of convergence …
elsevier.com
sci-hub.se 参考文章(82)
George Tellides, Denis A. Tereb, Nancy C. Kirkiles-Smith, Richard W. Kim, Jean H. Wilson, Jeffrey S. Schechner, Marc I. Lorber, Jordan S. Pober, Interferon-γ elicits arteriosclerosis in the absence of leukocytes Nature. ,vol. 403, pp. 207- 211 ,(2000) , 10.1038/35003221
David A. Frank, Sudipta Mahajan, Jerome Ritz, Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling Nature Medicine. ,vol. 5, pp. 444- 447 ,(1999) , 10.1038/7445
Claudia Niemand, Ariane Nimmesgern, Serge Haan, Patrick Fischer, Fred Schaper, Rolf Rossaint, Peter C. Heinrich, Gerhard Müller-Newen, Activation of STAT3 by IL-6 and IL-10 in Primary Human Macrophages Is Differentially Modulated by Suppressor of Cytokine Signaling 3 The Journal of Immunology. ,vol. 170, pp. 3263- 3272 ,(2003) , 10.4049/JIMMUNOL.170.6.3263
D. Guschin, N. Rogers, J. Briscoe, B. Witthuhn, D. Watling, F. Horn, S. Pellegrini, K. Yasukawa, P. Heinrich, G.R. Stark, A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. The EMBO Journal. ,vol. 14, pp. 1421- 1429 ,(1995) , 10.1002/J.1460-2075.1995.TB07128.X
J Yuan, U M Wegenka, C Lütticken, J Buschmann, T Decker, C Schindler, P C Heinrich, F Horn, The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Molecular and Cellular Biology. ,vol. 14, pp. 1657- 1668 ,(1994) , 10.1128/MCB.14.3.1657
David E. Levy, J. E. Darnell, STATs: transcriptional control and biological impact Nature Reviews Molecular Cell Biology. ,vol. 3, pp. 651- 662 ,(2002) , 10.1038/NRM909
Daniel J. Gough, David E. Levy, Ricky W. Johnstone, Christopher J. Clarke, IFNγ signaling—Does it mean JAK–STAT? Cytokine & Growth Factor Reviews. ,vol. 19, pp. 383- 394 ,(2008) , 10.1016/J.CYTOGFR.2008.08.004
Yutaka Takahashi, Nick Carpino, James C Cross, Miguel Torres, Evan Parganas, James N Ihle, SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. The EMBO Journal. ,vol. 22, pp. 372- 384 ,(2003) , 10.1093/EMBOJ/CDG057
James N Ihle, The Stat family in cytokine signaling. Current Opinion in Cell Biology. ,vol. 13, pp. 211- 217 ,(2001) , 10.1016/S0955-0674(00)00199-X
Roland Lang, Anne-Laure Pauleau, Evan Parganas, Yutaka Takahashi, Jörg Mages, James N Ihle, Robert Rutschman, Peter J Murray, SOCS3 regulates the plasticity of gp130 signaling Nature Immunology. ,vol. 4, pp. 546- 550 ,(2003) , 10.1038/NI932